FDA Inspection
Aurigene Pharmaceutical Services LimitedAurigene Pharmaceutical Services Limited – FDA Inspection, Feb 9, 2018
Record Details
This FDA Inspection record concerns Aurigene Pharmaceutical Services Limited, with an inspection on February 9, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- February 9, 2018
- Product Type
- Human Drugs
View Company Profile
ID · a6bab372-3844-4899-8111-857fcc233d3f
Inspection Facts
- Inspection number
- 1042489
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Aurigene Pharmaceutical Services Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Aurigene Pharmaceutical Services Limited
- FDA Inspection 1089349 - 2019-03-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.